Luminex will complete the final stages of its multi-year effort to expand the use of the aries? Sars-COV-2 assay. This includes completing the final clinical report, documenting the clinical studies…
Ended Purchase Order Awarded Last action
- Contract number
- 75A50122P00023
- Awardee
-
Luminex Corp UEI VLLHHV5E3AL1
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $1,218,705
Award facts
- Opportunity
-
- Luminex Corporation ARIES SARS-CoV-2 FDA 510(k) Clearance Special Notice · 75A50122R00025 · Posted Jul 12, 2022
- Contract value 100% obligated
- $1,218,705.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Austin, TX 78727, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $1,218,705 |
About this award
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded Luminex Corporation a $1.2 million firm-fixed price purchase order to complete the final stages of obtaining FDA 510(k) clearance for its proprietary ARIES Flu A/B/RSV + SARS-CoV-2 diagnostic test. Luminex will perform necessary clinical evaluations and submit the 510(k) application to achieve long-term FDA clearance of the ARIES test, which the agency considers critical to its pandemic response efforts. The work will be conducted in Austin, Texas over a four-month period concluding in January 2023. No subcontractors were identified. The original solicitation sought through a sole-source notice to have Luminex obtain FDA clearance for its ARIES diagnostic platform, as the agency determined Luminex was the only company capable of performing this work due to proprietary technology involved.
Description
Luminex will complete the final stages of its multi-year effort to expand the use of the aries? Sars-COV-2 assay. This includes completing the final clinical report, documenting the clinical studies and assay verification for barda and preparing a
Quick answers
Who was awarded contract 75A50122P00023?
75A50122P00023 was awarded to Luminex Corp by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 30, 2022.
How much is contract 75A50122P00023 worth?
The government has obligated $1,218,705 on 75A50122P00023.
Was contract 75A50122P00023 competed?
The extent of competition for 75A50122P00023 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award